• Neuromedin S (rat): Assay Workflow Guide

  2026-09-22

  Neuromedin S (rat) provides a defined rat peptide agonist for controlled neuromedin U receptor signaling and GPCR/G protein signaling assays. This guide addresses preparation, controls, and troubleshooting when directly matched paper evidence is unavailable; the product is for laboratory research, not diagnostic, therapeutic, or clinical use.

• EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Workflow

  2026-09-22

  Use dual fluorescence to separate mRNA uptake from productive translation in one experiment. This workflow shows how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) can benchmark nanoparticles, optimize transfection, and expose delivery bottlenecks with practical, quantitative readouts.

• BOP Reagent Workflow for Peptide and Prodrug Chemistry

  2026-09-21

  BOP reagent enables practical carboxyl group activation, phenyl ester preparation, and amide bond formation in research-scale peptide workflows. This guide connects reaction setup and troubleshooting to assay planning inspired by a carrier-free, ROS-responsive OSCC prodrug study without conflating synthetic chemistry evidence with biological validation.

• Fluorescein TSA Fluorescence System Kit Guide

  2026-09-21

  Learn how to apply HRP-driven tyramide deposition for sensitive protein, DNA, and RNA imaging in fixed tissues and cells. This workflow-focused guide connects the Fluorescein TSA Fluorescence System Kit to intestinal repair research, low-abundance target detection, and practical troubleshooting.

• IR-820: From Fluorescence to Evidence

  2026-09-20

  IR-820, also known as New Indocyanine Green, can support vascular and tumor imaging when optical signal is separated from biological interpretation. This guide presents an evidence-centered workflow for near-infrared fluorescence imaging, assay controls, and responsible translation of nanomedicine findings.

• Self-Adaptive Nanocarriers in Pancreatic Cancer

  2026-09-19

  This ACS Nano study introduces DATCPT, a pH/reactive oxygen species-responsive nanocarrier designed to move through blood, activate in the acidic pancreatic tumor microenvironment, and use ROS-linked chemistry to improve stromal penetration. Its importance lies in coordinating drug release, extracellular matrix remodeling, mitochondrial disruption, and metastasis control rather than treating delivery as a single accumulation problem.

• SOD Activity: From ROS Signal to Translational Evidence

  2026-09-18

  A mechanistic and strategic guide to measuring functional SOD activity, validating colorimetric ROS workflows, avoiding misleading peroxide readouts, and using assay data responsibly in translational research.

• CB-839 (Telaglenastat) Workflow for GLS1 Studies

  2026-09-18

  CB-839 (Telaglenastat) provides a selective pharmacological handle for separating GLS1-dependent glutaminolysis from broader metabolic effects. This guide combines viability, glutamate, isotope-tracing, protein, and autophagy readouts to strengthen cancer metabolism research and preclinical cancer drug evaluation.

• GS967 for Cardiac Late Sodium Current Studies

  2026-09-17

  This scenario-driven guide explains how GS967 (SKU B5850) can support mechanistic cardiac electrophysiology, arrhythmia prevention research, and orthogonal viability testing. It connects formulation, concentration selection, controls, and interpretation to evidence on late sodium current during aging and cardiac stress.

• Fluorescein TSA Kit for Sensitive Detection

  2026-09-17

  The Fluorescein TSA Fluorescence System Kit uses HRP-catalyzed tyramide deposition to increase localized fluorescence in IHC, ICC, and ISH. Its fluorescein readout supports fluorescence detection of low-abundance biomolecules, while the supplied evidence shows that assay specificity and quantitative interpretation still require independent validation.

• Microlipophagy and Radioresistance in SCLC

  2026-09-16

  A 2026 study identifies microlipophagy-driven lipid droplet remodeling as a metabolic adaptation associated with radioresistance in small-cell lung cancer. Its combined imaging, lipid analysis, pharmacological inhibition, and transcriptomic design provides a useful framework for testing whether autophagy-dependent lipid handling can be therapeutically disrupted.

• Recombinant Mouse CD4, Tag Free in Immune Assays

  2026-09-16

  Recombinant Mouse CD4, Tag Free provides a defined soluble CD4 reagent for binding, assay-development, and immunology workflows. This guide explains how a tag-free format can improve experimental control while connecting CD4 assay design to recent findings on TNFα, macrophage signaling, and glioma stem-cell biology.

• Staurosporine: Broad-Spectrum Kinase Inhibitor

  2026-09-15

  Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor used to interrogate kinase signaling and induce apoptosis in cancer cell lines. Product data report nanomolar protein kinase C activity, receptor-specific autophosphorylation effects, DMSO compatibility, and cold-storage requirements, while peer-reviewed work shows that near-death survival can alter tumor-cell states.

• Staurosporine: From Kinase Tool to Metastasis

  2026-09-15

  Staurosporine is a broad-spectrum serine/threonine protein kinase inhibitor with value beyond routine apoptosis assays. This article explains how to use its network-level pharmacology to interrogate motility, invasion, angiogenesis, and metastatic signaling while avoiding misleading interpretations caused by cytotoxicity.

• rTMS, GABAergic Neurons, and Amyloid Clearance

  2026-09-14

  This study identifies a cellular mechanism linking repetitive transcranial magnetic stimulation (rTMS) with amyloid clearance and cognitive recovery in a 5xFAD mouse model. Its central contribution is the association of GABAergic neuron-derived Cx3cl1 signaling with Cx3cr1-dependent microglial activity, reduced plaque burden, and lower neuroinflammation.

8565 records 1/571 page Next 12345 下5页 Last page